The cost of COVID-19 on lung cancer progress

The cost of COVID-19 on lung cancer progress

Lung cancer is the largest cause of cancer deaths in the world and there is no doubt that the COVID-19 pandemic has had a...
How the NHS and pharma are working together to improve cancer services

How the NHS and pharma are working together to improve cancer services

Despite a difficult year for cancer services, cancer survival rates are improving in the UK, and it is vital that all parts of the...

The importance of adherence

What makes the difference between a patient with a chronic condition adhering or not adhering to treatment? Poor adherence to treatment of chronic disease has...
How National Patient Recruitment Centres will aid clinical research

How National Patient Recruitment Centres will aid clinical research

New National Patient Recruitment Centres (NPRCs) are set to provide opportunities for local patients to be involved with invaluable clinical research studies and trials....
NHS Reset report - diving into the detail

NHS Reset report – diving into the detail

COVID-19 has exacerbated many of the health and care services’ pre-existing challenges. But it has also shown what teams can achieve when they have...
AF Toolkit to tackle avoidable strokes

AF Toolkit to tackle avoidable strokes

With approximately 15,000 people a year being admitted to hospital following an atrial fibrillation (AF) related stroke, the AHSN Network launched the AF Toolkit...
Is your sales force effective, post-pandemic?

Is your sales force effective, post-pandemic?

Kevin Lennon, Business Unit Director, Star OUTiCO, has over 17 years of industry experience, with a demonstrated history of leading teams to effectively operate...
Guide to pharma e-detailing

Guide to pharma e-detailing

Mehrnaz Campbell, Founding Director of Cheemia and Lindsey Brookes, an E-Detailing Consultant for Cheemia look how the COVID-19 pandemic has moved a large proportion...
How has Covid-19 affected how sales professionals engage with their customers?

How sales professionals can engage with their customers during COVID-19

The impact of COVID-19 has affected how sales professionals engage with customers. What does the way forward look like? Richard Gray and Stephen Dempster...
Current trends in compliance

Current trends in compliance

The COVID-19 pandemic has taught us many lessons, but are we missing an age-old one that we all need to learn and act upon?...

Latest articles

Antibiotic Research UK launches small research grants programme

Antibiotic Research UK launches small research grants programme

Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, has just launched its largest grants programme to date, the 2021 Small...
First AI-designed Immuno-oncology drug to enter clinical trials

First AI-designed Immuno-Oncology drug to enter clinical trials

Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
ViiV Healthcare's long-acting injectable HIV treatment authorised in EU

The first self-administered B-cell therapy for patients with relapsing forms of MS

Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New COVID-19 test reduces testing time from 30 minutes to five

New COVID-19 test reduces testing time from 30 minutes to five

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
First AI-designed Immuno-oncology drug to enter clinical trials

First AI-designed Immuno-Oncology drug to enter clinical trials

Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription